Hints and tips:
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...Chantelle Cseh Partner, Davies Ward Phillips & Vineberg As an associate in 2015, Chantelle Cseh designed a model to conduct a paperless trial for the Husky Injection Molding Systems v Robert Schad litigation...
...We are going to point out what the virtues are,” Mr Phillips says. —————- Controversial deals 3: Ceta What is it?...
...Museums are holding special shows, from Performing for the Camera at Tate Modern to Paul Strand at the V&A, while many commercial art galleries have put on photography: for instance, Shigeo Anzaï at White...
...asks Todd Phillips, director of the three Hangover films....
...Kevin Phillips of Moore Stephens, a professional services firm, said: “The challenge would be to secure this benefit without also crystallising a taxable gain in the US as Pfizer transferred its foreign...
...“Ensuring innovations are sufficiently protected is important for every industry in Britain, not just the pharmaceutical industry,” said Berkeley Phillips, medical director for Pfizer in the UK....
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...High profile disposals include ConocoPhillips spinning off its $20.7bn Phillips 66 business, and Pfizer selling its infant nutrition business to Nestlé for $11.85bn....
...Earnings Amazon.Com Q4 $0.27 ($0.38) Eli Lilly Q4 $0.79 ($0.87) Ford Motor Q4 $0.26 ($0.20) Harley-Davidson Q4 $0.31 ($0.24) Pfizer Q4 $0.44 ($0.50) Philips FY €1.15 (€0.21) T Rowe Price Q4 $0.89...
...Drugmaker Pfizer fell 0.9 per cent to $23.72. The company filed plans for an initial public offering of Zoetis, its animal health unit. JPMorgan Chase edged up 0.1 per cent to $36.99....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...Companies in the oil sector, notably Conoco-Phillips , have decided to divide downstream refining from exploration and production operations....
...Deal activity and changes at the top of Pfizer and Kellogg failed to stop US stocks following global markets slightly lower....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...David Pilling: Reason v emotion in China’s growth story This year, the consensus is for China to grow even faster than last year as exports pick up and record investment continues, says the FT’s Pilling....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
...This spurred groups such as Pfizer of the US and Roche of Switzerland to strike multi-billion-dollar deals during the first half of this year....
...www.russiandesignshow.com Syl Tang tracks trends and runs HipGuide Inc, ceo@hipguide.com...
...US business has hired some of the country’s most powerful lawyers to lobby the court to take its side in the case, Stoneridge v Scientific-Atlanta....
...Kindler, Chairman and CEO, Pfizer Inc., USA Klaus Kleinfeld, President and CEO, Siemens AG, Germany Mustafa V....
...Conoco Phillips fell 6.2 per cent to $57.75, Amerada Hess lost 5.3 per cent $112.75, Chevron slid 4.4 per cent to $55.75 and Exxon Mobil gave up 3.3 per cent at $55.26....
International Edition